BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18373706)

  • 21. A matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy?
    Strati P; Caligaris-Cappio F
    Curr Opin Oncol; 2011 Sep; 23(5):455-60. PubMed ID: 21681094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopenia.
    Strati P; Wierda W; Burger J; Ferrajoli A; Tam C; Lerner S; Keating MJ; O'Brien S
    Cancer; 2013 Nov; 119(21):3805-11. PubMed ID: 23943357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of Chronic Lymphocytic Leukemia Using iwCLL 2018 Compared with NCI-WG96 Criteria in Cipto Mangunkusumo Hospital: A Practical Consideration in Resource Limited Setting.
    Sukrisman L; Rinaldi I
    Acta Med Indones; 2022 Oct; 54(4):531-539. PubMed ID: 36624709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prevalence and prognostic significance of autoimmune cytopenias in a cohort of Egyptian patients with chronic lymphocytic leukemia.
    Atef B; Azmy E; Aladle D; Mabed M
    Hematol Oncol Stem Cell Ther; 2019 Jun; 12(2):97-104. PubMed ID: 30802421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Improvement of autoimmune cytopenia with ibrutinib in a chronic lymphocytic leukemia patient complicated by monoclonal immunoglobulin deposition disease].
    Nakamura M; Yoshioka S; Yamashita D; Hara S; Ishikawa T
    Rinsho Ketsueki; 2019; 60(10):1449-1454. PubMed ID: 31695006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruption.
    Garces S; Khoury JD; Kanagal-Shamanna R; Salem A; Wang SA; Ok CY; Hu S; Patel KP; Routbort MJ; Luthra R; Tang G; Schlette EJ; Bueso-Ramos CE; Medeiros LJ; Loghavi S
    Hum Pathol; 2018 Dec; 82():215-231. PubMed ID: 30086334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.
    Call TG; Norman AD; Hanson CA; Achenbach SJ; Kay NE; Zent CS; Ding W; Cerhan JR; Rabe KG; Vachon CM; Hallberg EJ; Shanafelt TD; Slager SL
    Cancer; 2014 Jul; 120(13):2000-5. PubMed ID: 24711224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Principal clinical features and prognosis in chronic lymphocytic leukemia.
    Degos L; Feingold N; Bastin C; Rain JD
    Nouv Rev Fr Hematol (1978); 1978 Nov; 20(3):359-76. PubMed ID: 754171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and prognostic evaluation of bone marrow infiltration (biopsy versus aspirate) in early chronic lymphocytic leukemia. A single center study.
    Molica S; Tucci L; Levato D; Docimo C
    Haematologica; 1997; 82(3):286-90. PubMed ID: 9234573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia.
    Visco C; Ruggeri M; Laura Evangelista M; Stasi R; Zanotti R; Giaretta I; Ambrosetti A; Madeo D; Pizzolo G; Rodeghiero F
    Blood; 2008 Feb; 111(3):1110-6. PubMed ID: 17986663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune complications in chronic lymphocytic leukaemia (CLL).
    Zent CS; Kay NE
    Best Pract Res Clin Haematol; 2010 Mar; 23(1):47-59. PubMed ID: 20620970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma.
    Parikh SA; Habermann TM; Chaffee KG; Call TG; Ding W; Leis JF; Macon WR; Schwager SM; Ristow KM; Porrata LF; Kay NE; Slager SL; Shanafelt TD
    Am J Hematol; 2015 Apr; 90(4):334-8. PubMed ID: 25581025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes Mellitus Is Associated with Inferior Prognosis in Patients with Chronic Lymphocytic Leukemia: A Propensity Score-Matched Analysis.
    Gao R; Man TS; Liang JH; Wang L; Zhu HY; Wu W; Fan L; Li JY; Yang T; Xu W
    Cancer Res Treat; 2020 Jan; 52(1):189-206. PubMed ID: 31291713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and serological autoimmune complications in chronic lymphocytic leukemia.
    Demir C; Ekinci Ö
    Wien Klin Wochenschr; 2017 Aug; 129(15-16):552-557. PubMed ID: 28477093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of bone marrow histology in chronic lymphocytic leukemia. A study of 335 untreated cases from a single institution.
    Mauro FR; De Rossi G; Burgio VL; Caruso R; Giannarelli D; Monarca B; Romani C; Baroni CD; Mandelli F
    Haematologica; 1994; 79(4):334-41. PubMed ID: 7806088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial.
    Farooqui MZ; Valdez J; Martyr S; Aue G; Saba N; Niemann CU; Herman SE; Tian X; Marti G; Soto S; Hughes TE; Jones J; Lipsky A; Pittaluga S; Stetler-Stevenson M; Yuan C; Lee YS; Pedersen LB; Geisler CH; Calvo KR; Arthur DC; Maric I; Childs R; Young NS; Wiestner A
    Lancet Oncol; 2015 Feb; 16(2):169-76. PubMed ID: 25555420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
    Rossignol J; Michallet AS; Oberic L; Picard M; Garon A; Willekens C; Dulery R; Leleu X; Cazin B; Ysebaert L
    Leukemia; 2011 Mar; 25(3):473-8. PubMed ID: 21127498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoimmune Cytopenia in CLL: Prognosis and Management in the Era of Targeted Therapies.
    Albiol N; Moreno C
    Cancer J; 2021 Jul-Aug 01; 27(4):286-296. PubMed ID: 34398555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural history of stage A chronic lymphocytic leukaemia untreated patients. French Cooperative Group on Chronic Lymphocytic Leukaemia.
    Br J Haematol; 1990 Sep; 76(1):45-57. PubMed ID: 2223648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.